BeOne Medicines Ltd. 4

BeOne Medicines Ltd. President and COO Wu Xiaobin sold 280 ADSs of BeOne Medicines Ltd. at about $380 per ADS on August 25, 2026 under a Rule 10b5-1 plan.

On August 25, 2026, BeOne Medicines Ltd. President and COO Wu Xiaobin sold 280 American Depositary Shares (ADSs) of the company at an implied price of approximately $380 per ADS, for an estimated total value of about $106,400, in a transaction executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 7, 2025. Following the sale, Wu retained direct ownership of 12,365 ADSs and 1,270,084 ordinary shares of BeOne Medicines, as well as 4,000 ADSs held indirectly by his wife; using the indicated transaction price, his aggregate post-transaction ownership is valued at roughly $34.9 million, reflecting a substantial continuing stake in the company.

Filing Facts

CIK

1651308

Ticker

ONC

Form

4

Source Type

fda

Accession

0001739452-26-000011

Alert Tier

5